Campbell & CO Investment Adviser LLC Buys Shares of 26,699 Arteris, Inc. $AIP

Campbell & CO Investment Adviser LLC purchased a new position in shares of Arteris, Inc. (NASDAQ:AIPFree Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 26,699 shares of the company’s stock, valued at approximately $254,000. Campbell & CO Investment Adviser LLC owned 0.06% of Arteris as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently modified their holdings of the business. Acadian Asset Management LLC increased its stake in Arteris by 40.6% during the 1st quarter. Acadian Asset Management LLC now owns 900,723 shares of the company’s stock valued at $6,222,000 after buying an additional 260,277 shares during the period. Acuitas Investments LLC acquired a new stake in shares of Arteris in the 2nd quarter worth approximately $858,000. Jacobs Levy Equity Management Inc. boosted its holdings in shares of Arteris by 48.5% in the first quarter. Jacobs Levy Equity Management Inc. now owns 249,517 shares of the company’s stock valued at $1,724,000 after acquiring an additional 81,516 shares in the last quarter. Public Employees Retirement System of Ohio bought a new position in shares of Arteris in the second quarter valued at approximately $203,000. Finally, AlphaQuest LLC increased its stake in shares of Arteris by 65.1% during the second quarter. AlphaQuest LLC now owns 64,504 shares of the company’s stock valued at $615,000 after acquiring an additional 25,426 shares during the period. Institutional investors own 64.36% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the company. Cowen restated a “buy” rating on shares of Arteris in a research report on Wednesday, November 5th. Weiss Ratings restated a “sell (d-)” rating on shares of Arteris in a report on Wednesday, October 8th. Jefferies Financial Group raised Arteris to a “hold” rating in a research note on Tuesday, October 28th. Rosenblatt Securities boosted their price target on shares of Arteris from $14.00 to $20.00 and gave the stock a “buy” rating in a research report on Wednesday, November 5th. Finally, Wall Street Zen raised shares of Arteris from a “sell” rating to a “hold” rating in a report on Monday, September 15th. Four equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Arteris presently has a consensus rating of “Moderate Buy” and an average target price of $17.50.

Get Our Latest Research Report on AIP

Insider Buying and Selling

In related news, CEO K Charles Janac sold 50,000 shares of the company’s stock in a transaction on Wednesday, October 8th. The stock was sold at an average price of $13.07, for a total transaction of $653,500.00. Following the transaction, the chief executive officer directly owned 9,689,071 shares of the company’s stock, valued at approximately $126,636,157.97. The trade was a 0.51% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, major shareholder Bayview Legacy, Llc sold 50,000 shares of the stock in a transaction dated Wednesday, October 8th. The stock was sold at an average price of $13.07, for a total value of $653,500.00. Following the completion of the sale, the insider directly owned 9,689,071 shares of the company’s stock, valued at approximately $126,636,157.97. This represents a 0.51% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 503,980 shares of company stock valued at $6,221,305. 33.70% of the stock is currently owned by company insiders.

Arteris Price Performance

Shares of AIP opened at $13.37 on Tuesday. The company has a 50-day moving average of $12.24 and a two-hundred day moving average of $10.01. The stock has a market cap of $584.00 million, a price-to-earnings ratio of -16.11 and a beta of 1.49. Arteris, Inc. has a one year low of $5.46 and a one year high of $15.92.

Arteris (NASDAQ:AIPGet Free Report) last issued its quarterly earnings results on Tuesday, November 4th. The company reported ($0.09) EPS for the quarter, beating the consensus estimate of ($0.11) by $0.02. Arteris had a negative net margin of 52.25% and a negative return on equity of 8,546.17%. The business had revenue of $17.41 million during the quarter, compared to the consensus estimate of $17.00 million. Arteris has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS. Analysts anticipate that Arteris, Inc. will post -0.73 earnings per share for the current year.

Arteris Company Profile

(Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Read More

Institutional Ownership by Quarter for Arteris (NASDAQ:AIP)

Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.